Terumo Europe

What Terumo Europe does

Terumo Europe N.V. is the EMEA operating subsidiary of Terumo Corporation (TSE: 4543), a Japanese medical technology group founded in 1921 and headquartered in Leuven, Belgium with a European Distribution Center in Genk and manufacturing at Heverlee (Belgium) and, as of September 2025, Leverkusen (Germany). The company operates five business units — Interventional Systems, Cardiovascular, Pharmaceutical Solutions, Hospital Care Solutions, and Life Care Solutions — covering the full care continuum from hospital-based interventional cardiology and cardiac surgery to home-based diabetes management. Its product portfolio includes proprietary vascular access and closure devices (Glidesheath Slender, FemoSeal, Angio-Seal VIP, Radifocus introducers, Optitorque and Glidecath angiographic catheters, FineCross M3/MG microcatheters, Radifocus Guide Wire M, TR Band, Ultimaster Nagomi coronary stent), cardiac surgery equipment (CDI OneView patient monitoring, VirtuoSaph Plus EVH systems, perfusion circuits, surgical stabilization products), prefilled syringe and CDMO capabilities (Polymer Prefillable Syringe Platform, fill-and-finish services for vials and syringes), and hospital and home care products (Agani safety needles, Terufusion infusion pumps, Surshield IV catheters, Nanopass 32.5G/34G pen needles, Medisafe Fit Smile blood glucose meters). Underpinning the portfolio are several proprietary technology platforms, including Mcoat hydrophilic coating, Thin-Wall construction, Nanopass asymmetric bevel pen-needle design, bioabsorbable active closure systems (FemoSeal, Angio-Seal), Nitinol super-elastic guidewire cores, and modular real-time patient monitoring with up to 22 parameters.

Terumo Europe generates revenue almost entirely through direct B2B sales of medical hardware and pharmaceutical containers, with no consumer e-commerce or retail channel. The go-to-market model is enterprise field sales: dedicated sales offices across EMEA, supported by a centralized European Distribution Center, sell directly to hospitals, healthcare professionals, cardiac surgery teams, and (since the Leverkusen acquisition) biopharmaceutical companies. Pricing is not publicly disclosed and is negotiated contract-by-contract, consistent with medtech OEM practice. The Pharmaceutical Solutions business unit additionally operates a CDMO model offering integrated services from primary container development through fill-and-finish and device assembly for combination products — a higher-margin services overlay on the underlying device franchise. Customer segments are diversified across interventional cardiologists and radiologists, cardiac and vascular surgeons, hospital departments, patients with diabetes, and biopharmaceutical companies, with no individual named customer accounting for a disproportionate share of revenue.

The strategic posture is expansionary: the September 2025 acquisition of WuXi Biologics' Leverkusen Drug Product Plant (~150 employees, 13,000 sqm cGMP-compliant site) established Terumo's first European CDMO base and a fourth global CDMO facility alongside three Japanese plants. October 2025 brought EU MDR certification of the CDI OneView Monitoring System, enabling full commercial launch across EMEA. Operational investments include ~2,000 solar panels at Leuven, a shift of ~1,000 containers per year from truck to barge transport (76% carbon footprint reduction), Factory of the Future 2026-2028 recognition at Heverlee, ISO 14001/45001 certifications (2024-2027), and EcoVadis Silver Medal / CDP A-List sustainability credentials, all reinforcing positioning for ESG-conscious European hospital procurement.

Name

Terumo Europe

Legal name

Terumo Europe N.V.

Website

https://terumo-europe.com

Company type

Private

Founded year

1921

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Terumo Europe N.V. is the EMEA medical device subsidiary of Terumo Corporation, manufacturing proprietary devices across interventional systems, cardiovascular, pharmaceutical solutions, hospital care, and life care. It sells directly to hospitals, clinicians, and biopharmaceutical firms in EMEA.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

akta.pro secondary industries

Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Medical devices
• Interventional cardiology
• Vascular access
• Pharmaceutical solutions
• Diabetes management

Headquarters

HQ city

Leuven

HQ country

Belgium

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales (Direct): Terumo Europe manufactures, distributes, markets, and sells a vast range of medical devices across five business units: Interventional Systems, Cardiovascular, Pharmaceutical Solutions, Hospital Care Solutions, and Life Care Solutions. Products include introducer sheaths, catheters, guidewires, closure devices, monitoring systems, perfusion circuits, needles, syringes, blood glucose meters, and infusion pumps. Revenue is generated through direct B2B sales to hospitals, healthcare professionals, and pharmaceutical companies across EMEA.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Terumo Europe manufactures, distributes, and sells a broad portfolio of medical devices across five business units: Interventional Systems (introducer sheaths, catheters, guidewires, closure devices, stents), Cardiovascular (perfusion circuits, monitoring systems, vessel harvesting), Pharmaceutical Solutions (prefillable syringes, CDMO fill-and-finish services), Hospital Care Solutions (safety needles, infusion pumps, IV catheters), and Life Care Solutions (blood glucose meters, pen needles, lancing devices). Products are sold directly to hospitals, healthcare professionals, cardiac surgery teams, and biopharmaceutical companies across EMEA.

Product overview

Terumo Europe is a healthcare technology company organized into five business units: Interventional Systems (IS), Cardiovascular (CV), Pharmaceutical Solutions (PSD), Hospital Care Solutions (HCS), and Life Care Solutions (LCS). The Interventional Systems portfolio includes vascular access and closure products such as FineCross™ M3/MG microcatheters, Glidesheath Slender™ introducer sheaths, FemoSeal™ and Angio-Seal™ VIP vascular closure devices, Radifocus™ Optitorque™ and Glidecath™ angiographic catheters, and Radifocus™ Guide Wire M family guidewires. The Cardiovascular portfolio includes CDI OneView™ patient monitoring systems, VirtuoSaph™ Plus EVH systems, perfusion circuits, and surgical stabilization products. Hospital Care Solutions offers Terumo Agani™ safety needles, Terufusion™ infusion pumps, and Surshield™ IV catheters. Life Care Solutions provides diabetes management products including Medisafe Fit Smile™ blood glucose meters, Nanopass™ pen needles, and lancing devices. Pharmaceutical Solutions focuses on CDMO services and prefilled syringe manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• Interventional Systems (IS): Business unit expanding the potential of vascular treatment to improve patient comfort
• Cardiovascular (CV)
• Pharmaceutical Solutions (PSD)
• Hospital Care Solutions (HCS)
• Life Care Solutions (LCS)
• Terumo Learning Edge
• TRI-HERO Challenge
• Angio-Seal VIP
• FemoSeal
• Glidesheath Slender
• CDI OneView
• Ultimaster Nagomi
• Terufusion
• Medisafe Fit Smile
• Agani
• Nanopass
• Surshield Versatus
• FineCross M3
• Radifocus Optitorque
• Radifocus Glidecath
• Radifocus Guide Wire M Family
• TR Band
• Progreat Lambda

Products and services

• FineCross M3 Coronary Micro-Guide Catheter Coronary micro-guide catheter for challenging cases involving tortuous vessels, CTO, bifurcations, and calcified lesions. Features a 1.7Fr tapered distal tip, enhanced distal flexibility, next-generation hydrophilic coating, and PTFE inner layer. Used by interventional cardiologists.
• FineCross MG Coronary Micro-Guide Catheter Coronary micro-guide catheter with hydrophilic coating, flexible distal segment, tapered design from 2.6Fr proximally to 1.8Fr distally, fully stainless-steel braided shaft, and PTFE inner layer, designed to provide crossability and guidewire support for complex lesions.
• Glidesheath Slender Introducer Sheath Thin-wall radial access introducer sheath available in 5Fr, 6Fr, and 7Fr sizes. Features Mcoat hydrophilic coating and thin-wall technology enabling 1Fr reduction in outer diameter while maintaining inner lumen. Used for transradial coronary and peripheral interventions.
• FemoSeal Vascular Closure System Vascular closure system providing mechanical femoral artery closure via a 3-step deployment process and bioabsorbable seal (inner sealing disc, outer locking disc, and bioabsorbable suture) for rapid haemostasis and early ambulation. Used in catheterization procedures.
• Angio-Seal VIP Vascular Closure Device Vascular closure device for common femoral arterial puncture sites with 3-step deployment (locate, set, seal), bioabsorbable anchor, collagen plug, and bioabsorbable suture. Complete bioabsorption within 90 days. Available in 6Fr and 8Fr.
• Radifocus Optitorque Angiographic Catheter Angiographic catheter with torque control close to 1:1 via double-braided stainless steel mesh, thin-wall shaft for high-flow contrast delivery, and over 150 available tip shapes for coronary, cerebral, and visceral procedures.
• Radifocus Glidecath Hydrophilic Angiographic Catheter Hydrophilic coated angiographic catheter with Mcoat coating technology, multi-layered tungsten-filled polyurethane jacket for radiopacity, and stainless steel braiding, designed for peripheral and neurovascular anatomy.
• Radifocus Guide Wire M Family Hydrophilic Nitinol guidewires in Standard, Half Stiff, and Stiff Types for peripheral, cerebral, and coronary interventions. Features super-elastic Nitinol core, Mcoat hydrophilic coating, tungsten-filled radiopaque polyurethane jacket, and atraumatic tapered tip.
• TR Band Radial Artery Compression Device Radial artery compression device for hemostasis after transradial procedures, part of the radial access closure solutions portfolio.
• Runthrough NS PTCA Guide Wire Family PTCA guide wire family for percutaneous transluminal coronary angioplasty procedures.
• Ultimaster Nagomi Sirolimus Eluting Coronary Stent System Sirolimus eluting coronary stent system for treatment of coronary artery disease.
• VirtuoSaph Plus Endoscopic Vessel Harvesting System Endoscopic vessel harvesting system for minimally invasive saphenous vein harvesting during coronary artery bypass graft surgery.
• CDI OneView Patient Monitoring System Next-generation modular, expandable patient parameter monitoring system for cardiopulmonary bypass surgery, displaying up to 22 vital parameters in real time (measured flow, cardiac index, regional cerebral oxygen saturation, oxygen extraction ratio, Area Under the DO2 Curve, and measured arterial oxygen saturation). MDR-certified.
• Perfusion Circuits (Oxygenators and Procedure Packs) Oxygenators and procedure packs for extracorporeal circulation. Terumo has over 40 years of history including the world's first hollow fiber oxygenator and first pediatric oxygenator with integrated arterial filter.
• Beating Heart and Surgical Stabilization Products Products offering versatile combination of stabilization, low profile, and easy positioning for cardiac surgery, including positive positioning and retraction for CABG and thoracoabdominal procedures.
• Terumo Agani Safety Hypodermic Needle Safety hypodermic needle with sharps protection mechanism featuring audible click confirmation and one-hand activation, ISO 6009 color-coded hub, sharp point with silicone coating. EO sterilized, 5-year shelf life, packaged 100 per unit box.
• Terufusion Open TCI Infusion Pump Open TCI (Target Controlled Infusion) pump for medical settings.
• Surshield Versatus IV Catheter with Protector IV catheter with protector designed for safe peripheral venous access.
• Nanopass 34G Pen Injector Needle Ultra-thin 34G needle for pen injectors designed to minimize pain during subcutaneous injection including insulin and human growth hormone.
• Nanopass 32.5G Pen Injector Needle Pen needle with diameter of only 32.5G (0.22mm) featuring asymmetric bevel that cuts skin instead of puncturing to reduce pain. Includes terumo-thin wall technology optimizing insulin flow. Available in three needle lengths for tailored patient selection.
• Medisafe Fit Smile Blood Glucose Meter Blood glucose meter for self-monitoring with color-coded blood glucose levels, step-by-step and voice guidance, bright large display, wireless NFC data transfer, and ISO 15197:2015 compliance. Designed for elderly and visually impaired patients.
• Medisafe Fit Blood Glucose Meter System Blood glucose meter system for diabetes management with compatible test strips.
• Medisafe Finetouch II Lancing Device Lancing device for blood glucose testing used as part of the diabetes management product line.
• CDMO Fill-and-Finish and Combination Product Services (Leverkusen Drug Product Plant) Contract Development and Manufacturing Organization (CDMO) services at the Leverkusen, Germany facility, providing fill-and-finish services for vials and polymer prefillable syringes, including device assembly for combination products. Serves biopharmaceutical companies launching injectable treatments.

Quantifiable outcome

• Time to hemostasis reduced by 95% vs manual compression with FemoSeal vascular closure device
• +10 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature12 records

Partnerships

One partnership is on record.

• WuXi BiologicscoreStrategic or Co-development Partner · 30 September 2025Terumo Corporation completed acquisition of a Drug Product Plant and associated Quality Control Laboratory operations from WuXi Biologics in Leverkusen, Germany, with the transaction closing on September 30, 2025. The plant features cGMP-compliant facilities for fill & finish services for vials and polymer prefillable syringes, including device assembly. Approximately 150 employees transferred to Terumo. This acquisition significantly expands Terumo's CDMO footprint in Europe, complementing existing facilities in Japan, and strengthens its ability to serve biopharmaceutical companies in launching effective injectable treatments.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Teleflex Incorporated: Global medical technology company focused on interventional access, anesthesia delivery, and surgical solutions. Direct comparator for Terumo Europe's Interventional Systems portfolio, particularly in radial access, vascular closure devices, and introducer sheaths, where Teleflex competes aggressively in EMEA.
• Nipro Corporation: Japan-headquartered medical device manufacturer with leading positions in needles, syringes, dialysis equipment, and hospital care products. Direct peer to Terumo Europe through its overlapping Japan-parented global medical device business — competing head-to-head in needles, syringes, and diabetes consumables across European hospital and home-care channels.
• Boston Scientific Corporation: Global interventional medical device company focused on interventional cardiology, peripheral interventions, and structural heart. Direct competitor to Terumo Europe's Interventional Systems business unit across coronary and peripheral vascular devices, including catheters, guidewires, and closure systems.
• B. Braun Melsungen AG: German-headquartered medical device and pharmaceutical company with leading portfolios in injection systems, infusion pumps, IV catheters, surgical instruments, and prefilled syringe solutions. Closest European peer to Terumo Europe's Hospital Care, Interventional, and Pharmaceutical Solutions units, often competing on shared hospital formulary contracts.
• West Pharmaceutical Services, Inc. Global manufacturer of pharmaceutical packaging components, drug delivery systems, and injectable solutions, including stoppers, seals, and prefillable syringe systems. Direct peer to Terumo Europe's Pharmaceutical Solutions business, competing for the same biopharma primary-container and combination-product contracts that the Leverkusen CDMO plant is being positioned to win.
• Becton Dickinson (BD): Global medical technology company with leading positions in vascular access, injection and infusion systems, surgical instruments, and biosciences. Directly comparable to Terumo Europe across the Interventional Systems (vascular access), Hospital Care Solutions (needles, syringes, IV catheters), and Life Care Solutions portfolios.
• ICU Medical, Inc. US-based medical device company specializing in IV therapy, infusion pumps, and vascular access devices following the Smiths Medical acquisition. Direct peer to Terumo Europe's Hospital Care Solutions and Terufusion infusion pump product lines, competing in both EU and broader EMEA tenders.
• Abbott Laboratories: Global diagnostics, medical devices, and nutrition company with strong positions in vascular and interventional cardiology devices plus the leading FreeStyle Libre continuous glucose monitoring franchise. Directly comparable to Terumo Europe's Interventional Systems (stents, catheters) and Life Care Solutions diabetes management portfolios.

Emerging players

• Edwards Lifesciences Corporation: Medical device company specializing in heart valve therapies, hemodynamic monitoring, and critical care technologies. Comparable to Terumo Europe on the cardiovascular surgery side, particularly in cardiopulmonary bypass monitoring (vs. Terumo's CDI OneView with 22 patient parameters), with overlapping perfusion and surgical customer bases.

Broad incumbents

• Medtronic plc: Largest medical device conglomerate globally with broad interventional cardiology, cardiac surgery, and vascular portfolios as part of a wider portfolio spanning diabetes, neuroscience, and surgical robotics. Comparable to Terumo Europe as a broad incumbent competing across multiple of its five business units rather than specializing in any single niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/terumo-europe

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terumo Europe